1. Stephens MA, Wand G. Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res. 2012; 34:468–483.
2. Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome. Int J Obes (Lond). 2009; 33:1249–1256.
Article
3. Du H, Liu L, Wang Y, Nakagawa Y, Lyzlov A, Lutfy K, Friedman TC, Peng X, Liu Y. Specific reduction of G6PT may contribute to downregulation of hepatic 11beta-HSD1 in diabetic mice. J Mol Endocrinol. 2013; 50:167–178.
Article
4. Wyrwoll CS, Holmes MC, Seckl JR. 11beta-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol. 2011; 32:265–286.
Article
5. Biedasek K, Andres J, Mai K, Adams S, Spuler S, Fielitz J, Spranger J. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. PLoS One. 2011; 6:e16674.
Article
6. Wake DJ, Walker BR. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol. 2004; 215:45–54.
Article
7. Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species. J Mol Endocrinol. 2005; 35:89–101.
Article
8. Singh Y, Kotwal N, Menon AS. Endocrine hypertension - Cushing's syndrome. Indian J Endocrinol Metab. 2011; 15:Suppl 4. S313–S316.
Article
9. Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2010; 17:217–223.
Article
10. Yeager MP, Pioli PA, Guyre PM. Cortisol exerts bi-phasic regulation of inflammation in humans. Dose Response. 2011; 9:332–347.
Article
11. Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011; 335:2–13.
Article
12. Chang JH, Lee KJ, Kim SK, Yoo DH, Kang TY. Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling model. Indian J Med Res. 2014; 139:117–124.
13. Song JS, Kim CH, Heo JY, Cho YS. Rosiglitazone reduces a wide range of proinflammatory profiles in synovial fibroblast SW982 under spheroid culture. Immunol Lett. 2010; 131:81–88.
Article
14. Cho YS, Kim CH, Cheon HG. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors. Anal Biochem. 2009; 392:110–116.
Article
15. Christiansen JJ, Djurhuus CB, Gravholt CH, Iversen P, Christiansen JS, Schmitz O, Weeke J, Jorgensen JO, Moller N. Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. J Clin Endocrinol Metab. 2007; 92:3553–3559.
Article
16. Monder C, Coufalik A. Influence of cortisol on glycogen synthesis and gluconeogenesis in fetal rat liver in organ culture. J Biol Chem. 1972; 247:3608–3617.
Article
17. Shultz TD, Bollman S, Kumar R. Decreased intestinal calcium absorption in vivo and normal brush border membrane vesicle calcium uptake in cortisol-treated chickens: evidence for dissociation of calcium absorption from brush border vesicle uptake. Proc Natl Acad Sci U S A. 1982; 79:3542–3546.
Article
18. Schwartz M. Glucocorticoids in allergic diseases. Acta Med Scand Suppl. 1969; 500:43–48.
Article
19. Alangari AA. Corticosteroids in the treatment of acute asthma. Ann Thorac Med. 2014; 9:187–192.
Article
20. Flammer JR, Rogatsky I. Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol Endocrinol. 2011; 25:1075–1086.
Article
21. Annane D. Glucocorticoids in the treatment of severe sepsis and septic shock. Curr Opin Crit Care. 2005; 11:449–453.
Article
22. Sedwick C. Wanted: a new model for glucocorticoid receptor transactivation and transrepression. PLoS Biol. 2014; 12:e1001814.
Article
23. Palacios R, Sugawara I. Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin-2 Producer T cells unresponsive to interleukin-1 and unable to synthesize the T-cell growth factor. Scand J Immunol. 1982; 15:25–31.
Article
24. Vukelic S, Stojadinovic O, Pastar I, Rabach M, Krzyzanowska A, Lebrun E, Davis SC, Resnik S, Brem H, Tomic-Canic M. Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem. 2011; 286:10265–10275.
Article
25. Yamazaki T, Yokoyama T, Akatsu H, Tukiyama T, Tokiwa T. Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone. In Vitro Cell Dev Biol Anim. 2003; 39:337–339.
Article
26. Esteves CL, Verma M, Rog-Zielinska E, Kelly V, Sai S, Breton A, Donadeu FX, Seckl JR, Chapman KE. Pro-inflammatory cytokine induction of 11beta-hydroxysteroid dehydrogenase type 1 in A549 cells requires phosphorylation of C/EBPbeta at Thr235. PLoS One. 2013; 8:e75874.
27. Itoi S, Terao M, Murota H, Katayama I. 11beta-Hydroxysteroid dehydrogenase 1 contributes to the proinflammatory response of keratinocytes. Biochem Biophys Res Commun. 2013; 440:265–270.
Article
28. Philip AM, Vijayan MM. Stress-immune-growth interactions: cortisol modulates suppressors of cytokine signaling and JAK/STAT pathway in rainbow trout liver. PLoS One. 2015; 10:e0129299.
Article
29. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax. 2000; 55:603–613.
Article
30. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med. 2005; 353:1711–1723.
Article
31. Castro R, Zou J, Secombes CJ, Martin SA. Cortisol modulates the induction of inflammatory gene expression in a rainbow trout macrophage cell line. Fish Shellfish Immunol. 2011; 30:215–223.
Article